About
This app provides educational resources and information for ophthalmologists and healthcare professionals. It focuses on advancing ophthalmology through continuing medical education and public awareness of eye health.
What's New in NEOS Eyes
2.12
December 3, 2025
Bug fixes and performance improvements
FAQ
What is NEOS Eyes?
NEOS Eyes is an educational application from the New England Ophthalmological Society, dedicated to the study and advancement of ophthalmology. It provides resources for continuing medical education and public awareness of eye health.
Who is NEOS Eyes for?
The app is primarily for ophthalmologists, including board-certified and board-eligible professionals in New England, as well as allied ophthalmic personnel. It also aims to educate other healthcare providers and the public.
How does NEOS Eyes help with continuing medical education?
NEOS Eyes is accredited by the Massachusetts Medical Society to provide continuing medical education for physicians. Members are typically eligible to receive up to 35 CME credits per year through the society's sponsored meetings.
What kind of eye conditions does NEOS Eyes cover?
The app focuses on educating users about various diseases and conditions of the eye, with an emphasis on detection, treatment, and prevention. Specific subspecialties are covered in their five annual meetings.
Is NEOS Eyes free to use?
Yes, NEOS Eyes is available for free. The New England Ophthalmological Society is a non-profit organization dedicated to its mission.
What devices does NEOS Eyes support?
NEOS Eyes is available on iPhone, iPad, and iPod devices, indicating compatibility with Apple's mobile operating systems.
How often is NEOS Eyes updated?
The app was last updated on December 3, 2025, with version 2.12. This suggests a commitment to maintaining and improving the application's content and functionality.
Does NEOS Eyes have ads?
No, NEOS Eyes does not contain advertisements. The app is free and focuses on delivering educational content without commercial interruptions.
